Organigram Global Inc Stock Price, News & Analysis

Organigram (NASDAQ: OGI) reported record Q2 Fiscal 2025 results, with gross revenue up 79% to $102.8 million and net revenue increasing 74% to $65.6 million. The company achieved net income of $42.5 million and Adjusted EBITDA of $4.9 million, compared to a loss in the previous year. International revenue grew 177% to $6.1 million. The company maintains a strong cash position of $83.4 million with negligible debt. Organigram holds #1 market share position in Canada across multiple categories including vapes, pre-rolls, and hash. The Motif integration is now expected to deliver $15 million in annual cost synergies, up from the original $10 million estimate. The company also acquired Collective Project, entering the U.S. and Canadian beverage categories with distribution in 10 states and six provinces.

Organigram Global Inc. (NASDAQ: OGI) has achieved significant recognition at the 2025 High Spirits Awards for its recently acquired brand, Collective Project. The company's hemp-derived THC beverages won a gold medal for Blood Orange, Yuzu & Vanilla and a platinum medal for Mango, Pineapple & Coconut flavors.

The products, which feature real fruit juice and are inspired by the global art community, are currently available across multiple U.S. states including Minnesota, Florida, Texas, and several others, with distribution through major retailers like Top Ten Liquors and Total Wine & More. Organigram plans to launch an eCommerce website in the coming weeks to support brand expansion.

This recognition comes shortly after Organigram's acquisition of Collective Project, validating the company's strategy to grow in the U.S. cannabis beverage market.

Organigram Global (NASDAQ: OGI) (TSX: OGI) has been awarded the "Exporter of the Year" at the 2025 New Brunswick Export Awards by Opportunities New Brunswick. The company, which is Canada's #1 cannabis company by market share, has demonstrated significant international growth with exports to Germany, the UK, and Australia.

Key achievements include:

• $50 million in international cannabis shipped sales since 2020
• $885 million in total shipped sales
• 725+ employees at Moncton facility
• Nearly $500 million invested in site development
• $34 million spent with local vendors
• $4 million investment in new substation with NB Power

As New Brunswick's fourth-largest private-sector employer, Organigram aims to position Canada to capture a share of the estimated $140 billion global cannabis market through federal engagement and a national cannabis export strategy.

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), currently holding the position of Canada's #1 cannabis company by market share, has scheduled its second quarter fiscal 2025 earnings release for Monday, May 12, 2025, before the market opens. The earnings will cover the period ended March 31, 2025.

The company will host a conference call at 8:00 am Eastern Time on the same day to discuss the results. Interested participants can register for the call through the provided link, with registration recommended at least 10 minutes before the call starts. A webcast replay will be available within 24 hours after the call and will remain accessible for 90 days on Organigram's investor relations website.

Organigram Global, Canada's leading cannabis company by market share, congratulates Mark Carney on winning the 2025 federal election. The company urges the new government to strengthen Canada's cannabis sector as a key economic driver.

CEO Beena Goldenberg outlines three immediate actions needed: reforming the tax framework to a 10% ad valorem rate, eliminating interprovincial trade barriers through a single national excise stamp by Canada Day 2025, and developing a national cannabis export strategy for the CAD $140 billion global market.

The legal cannabis industry has made significant economic contributions:

• Over $43 billion contributed to GDP since legalization
• Supports 80,000+ jobs nationwide
• Added $7.4 billion to Canada's GDP in 2024
• Outperforms breweries ($2.6B), forestry ($3.3B), and wineries/distilleries ($929M)

Public support is strong, with 64% of Canadians favoring increased government support for the sector's growth.

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada's #1 cannabis company by market share, has received multiple awards at the CNB Leadership Conference and Cannabis NB Cup. Three of its consumer brands - SHRED, Edison, and Trailblazer were recognized for excellence.

In the 2025 Cannabis NB Cup, held between February 3 and April 10, Trailblazer's Gary Dunk 3.5g secured 3rd place in the Indica category. SHRED received the Best In-Store Branding award for its retail presence, while Edison Sonics Kiwi Berry was named Best New Edible.

The company's SHRED brand has achieved over $250 million in annual retail sales, while Edison and Trailblazer brands are showing double-digit year-over-year growth in key categories.

Organigram Global (NASDAQ: OGI) (TSX: OGI), Canada's #1 cannabis company by market share, has released the recording of its OG Investor Session, now available online for shareholders, analysts, and industry stakeholders.

The virtual event features presentations from the company's senior leadership team, including tours of its five state-of-the-art facilities across Canada and a live Q&A session. CEO Beena Goldenberg emphasized the session's importance in communicating the company's growth trajectory and industry opportunities.

The recorded session covers key themes including:

• Strengthening Organigram's position as a global leader in branded cannabis products
• Leveraging science and IP for product innovation and margin expansion
• Updates on cost-efficiency programs and automation
• Progress on international sales and regulatory developments

Organigram Global (NASDAQ: OGI), Canada's leading cannabis company by market share, released new public opinion data showing strong national support for growing Canada's cannabis industry. The survey, conducted by Abacus Data in April 2025, reveals that 57% of Canadians view cannabis as important to today's economy, while 62% believe it could play an even more significant role in the future.

The poll shows that 64% of Canadians support increased federal government assistance for the legal cannabis sector, with support highest among ages 18-29 (73%) and maintaining majority support (57%) even among those 60 and over. Regional support is strongest in Atlantic Canada (65%), followed by the Prairies (64%), Ontario (62%), and British Columbia (61%).

The cannabis industry has contributed over $43 billion to GDP since legalization and supports 80,000 jobs nationwide. In 2024, it added $7.4 billion to Canada's GDP, surpassing traditional industries like breweries ($2.6B), forestry and logging ($3.3B), and wineries and distilleries ($1.2B).

Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) has announced its first-ever virtual investor event, the OG Investor Session, scheduled for April 10, 2025, at 4pm EST. The online event will provide investors with insights into the company's growth strategy and industry trends.

Key presenters include:

• CEO Beena Goldenberg discussing vision and market strategy
• CFO Greg Guyatt covering financial performance
• SVP Borna Zlamalik presenting R&D and innovation
• Director of IR Max Schwartz hosting

The event will feature behind-the-scenes facility tours and a live Q&A session with senior management. Additionally, the company has announced its official name change to Organigram Global Inc., with shares continuing to trade under the symbol 'OGI' on both TSX and NASDAQ. New CUSIP (68617J100) and ISIN (CA68617J1003) numbers have been assigned to common shares.